GB9928193D0 - Cell treatment method - Google Patents
Cell treatment methodInfo
- Publication number
- GB9928193D0 GB9928193D0 GBGB9928193.3A GB9928193A GB9928193D0 GB 9928193 D0 GB9928193 D0 GB 9928193D0 GB 9928193 A GB9928193 A GB 9928193A GB 9928193 D0 GB9928193 D0 GB 9928193D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment method
- cell treatment
- cell
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9928193.3A GB9928193D0 (en) | 1999-11-29 | 1999-11-29 | Cell treatment method |
PCT/GB2000/004542 WO2001040445A1 (en) | 1999-11-29 | 2000-11-29 | Cell isolation method |
AU17166/01A AU1716601A (en) | 1999-11-29 | 2000-11-29 | Cell isolation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9928193.3A GB9928193D0 (en) | 1999-11-29 | 1999-11-29 | Cell treatment method |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9928193D0 true GB9928193D0 (en) | 2000-01-26 |
Family
ID=10865360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9928193.3A Ceased GB9928193D0 (en) | 1999-11-29 | 1999-11-29 | Cell treatment method |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1716601A (en) |
GB (1) | GB9928193D0 (en) |
WO (1) | WO2001040445A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4194934B2 (en) | 2001-05-26 | 2008-12-10 | ワン セル システムズ インコーポレイテッド | Protein secretion by encapsulated cells |
ES2343721B1 (en) * | 2008-12-19 | 2011-06-06 | Histocell, S.L. | CELL TRANSPORTATION SYSTEM. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6277635B1 (en) * | 1992-03-04 | 2001-08-21 | Schering Corporation | Use of interleukin-10 to produce a population of suppressor cells |
EP0852618A1 (en) * | 1995-07-25 | 1998-07-15 | Celltherapy Inc. | Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
WO1999064560A1 (en) * | 1998-06-08 | 1999-12-16 | Basf Aktiengesellschaft | Methods for monitoring the stability of protein or cellular product secretion by cells in a fermenter culture |
-
1999
- 1999-11-29 GB GBGB9928193.3A patent/GB9928193D0/en not_active Ceased
-
2000
- 2000-11-29 WO PCT/GB2000/004542 patent/WO2001040445A1/en active Application Filing
- 2000-11-29 AU AU17166/01A patent/AU1716601A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU1716601A (en) | 2001-06-12 |
WO2001040445A1 (en) | 2001-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9918031D0 (en) | Method | |
GB9916757D0 (en) | Method | |
GB9928208D0 (en) | Method | |
GB0007871D0 (en) | Method | |
GB9915625D0 (en) | Method | |
GB9928193D0 (en) | Cell treatment method | |
GB9928206D0 (en) | Method | |
GB0002303D0 (en) | Method | |
GB0003893D0 (en) | Treating cells | |
GB9920334D0 (en) | Method | |
GB9926435D0 (en) | Method | |
GB9915936D0 (en) | Method | |
GB9924399D0 (en) | Method | |
GB9925202D0 (en) | Method | |
GB9707698D0 (en) | Cell treatment method | |
GB9909799D0 (en) | Method | |
GB0007007D0 (en) | Method | |
GB9908162D0 (en) | Method | |
GB0200956D0 (en) | Method | |
GB9928209D0 (en) | Method | |
GB0007869D0 (en) | Method | |
GB9915346D0 (en) | Method | |
GB9926994D0 (en) | Method | |
GB9906852D0 (en) | Method | |
GB9909988D0 (en) | Method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |